Reconstructing metastatic seeding patterns of human cancers

Nature Communications

Volumn 8, Issue , 2017, Pages

  Reiter, Johannes G ^a,b   Makohon Moore, Alvin P ^c   Gerold, Jeffrey M ^a   Bozic, Ivana ^a,d   Chatterjee, Krishnendu ^b   Iacobuzio Donahue, Christine A ^c   Vogelstein, Bert ^e   Nowak, Martin A ^a,d  

^a HARVARD UNIVERSITY   (United States)

^b INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; DNA;

CANCER; EVOLUTIONARY BIOLOGY; GENOME; HETEROGENEITY; HOMINID; PHYLOGENETICS; PHYLOGENY; RECONSTRUCTION; SEEDING; TUMOR;

ARTICLE; BAYES THEOREM; CANCER GROWTH; COMPUTER MODEL; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; GENETIC SIMILARITY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; METASTASIS POTENTIAL; MISMATCH REPAIR; OVARY CANCER; PANCREAS CANCER; PHYLOGENETIC TREE; POINT MUTATION; PRIMARY TUMOR; PROSTATE CANCER; SOMATIC MUTATION; TREEOMICS; TUMOR SEEDING; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; BENCHMARKING; CLASSIFICATION; FEMALE; GENETIC HETEROGENEITY; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; METABOLISM; MUTATION; OVARY TUMOR; PANCREAS TUMOR; PATHOLOGY; PHYLOGENY; PROCEDURES; PROSTATE TUMOR; PROTEOMICS;

BAYES THEOREM; BENCHMARKING; DNA, NEOPLASM; FEMALE; GENETIC HETEROGENEITY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MUTATION; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PHYLOGENY; PROSTATIC NEOPLASMS; PROTEOMICS;

EID: 85011690566     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14114     Document Type: Article

References (70)

1. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976)
2. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532 (1988)
3. Merlo, L. M. F., Pepper, J. W., Reid, B. J. & Maley, C. C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935 (2006)
4. Diaz, Jr L. A. et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537-540 (2012)
5. Bozic, I. et al. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife 2, e00747 (2013)
6. Naxerova, K. & Jain, R. K. Using tumour phylogenetics to identify the roots of metastasis in humans. Nat. Rev. Clin. Oncol. 12, 258-272 (2015)
7. Massaguei, J. & Obenauf, A. C. Metastatic colonization by circulating tumour cells. Nature 529, 298-306 (2016)
8. Turajlic, S. & Swanton, C. Metastasis as an evolutionary process. Science 352, 169-175 (2016)
9. Talmadge, J. E. & Fidler, I. J. The biology of cancer metastasis: historical perspective. Cancer Res. 70, 5649-5669 (2010)
10. McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15-26 (2015)
11. Hong, W. S., Shpak, M. & Townsend, J. P. Inferring the origin of metastases from cancer phylogenies. Cancer Res. 75, 4021-4025 (2015)
12. Campbell, P. J. et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl Acad. Sci. USA 105, 13081-13086 (2008)
13. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010)
14. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010)
15. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012)
16. Schuh, A. et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120, 4191-4196 (2012)
17. Cooper, C. S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367-372 (2015)
18. de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014)
19. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014)
20. Bashashati, A. et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J. Pathol. 231, 21-34 (2013)
21. Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353-357 (2015)
22. Brastianos, P. K. et al. Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1164-1177 (2015)
23. McPherson, A. et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat. Genet. 48, 758-767 (2016)
24. Beerenwinkel, N., Schwarz, R. F., Gerstung, M. & Markowetz, F. Cancer evolution: mathematical models and computational inference. Syst. Biol. 64, e1-e25 (2015)
25. Turajlic, S., McGranahan, N. & Swanton, C. Inferring mutational timing and reconstructing tumour evolutionary histories. Biochim. Biophys. Acta 1855, 264-275 (2015)
26. Kumar, A. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat. Med. 22, 369-378 (2016)
27. Makohon-Moore, A. P. et al. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nat. Genet. doi: 10.1038/ng.3764 (2017)
28. Naxerova, K. et al. Hypermutable DNA chronicles the evolution of human colon cancer. Proc. Natl Acad. Sci. USA 111, E1889-E1898 (2014)
29. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225-233 (2014)
30. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012)
31. Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525-530 (2015)
32. Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751-759 (2015)
33. Strino, F., Parisi, F., Micsinai, M. & Kluger, Y. TrAp: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res. 41, e165 (2013)
34. Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396-401 (2014)
35. Miller, C. A. et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput. Biol. 10, e1003665 (2014)
36. Deshwar, A. G. et al. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 16, 35 (2015)
37. Popic, V. et al. Fast and scalable inference of multi-sample cancer lineages. Genome Biol. 16, 91 (2015)
38. El-Kebir, M., Oesper, L., Acheson-Field, H. & Raphael, B. J. Reconstruction of clonal trees and tumor composition from multi-sample sequencing data. Bioinformatics 31, i62-i70 (2015)
39. Niknafs, N., Beleva-Guthrie, V., Naiman, D. Q. & Karchin, R. Subclonal hierarchy inference from somatic mutations: automatic reconstruction of cancer evolutionary trees from multi-region next generation sequencing. PLoS Comput. Biol. 11, e1004416 (2015)
40. Yuan, K., Sakoparnig, T., Markowetz, F. & Beerenwinkel, N. BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies. Genome Biol. 16, 36 (2015)
41. Malikic, S., McPherson, A. W., Donmez, N. & Sahinalp, C. S. Clonality inference in multiple tumor samples using phylogeny. Bioinformatics 31, 1349-1356 (2015)
42. Day, W. H. E. & Sankoff, D. Computational complexity of inferring phylogenies by compatibility. Syst. Biol. 35, 224-229 (1986)
43. Bonet, M., Steel, M., Warnow, T. & Yooseph, S. Better methods for solving parsimony and compatibility. J. Comput. Biol. 5, 391-407 (1998)
44. Felsenstein, J. Inferring Phylogenies 2, (Sinauer Associates, 2004)
45. Nakhleh, L., Ringe, D. & Warnow, T. Perfect phylogenetic networks: a new methodology for reconstructing the evolutionary history of natural languages. Language 81, 382-420 (2005)
46. Salari, R. et al. Inference of tumor phylogenies with improved somatic mutation discovery. J. Comput. Biol. 20, 933-944 (2013)
47. Hajirasouliha, I. & Raphael, B. J. in Algorithms in Bioinformatics. (eds Brown, D. & Morgenstern, B.) 354-367 (Springer, 2014)
48. Nemhauser, G. L. & Wolsey, L. A. Integer and Combinatorial Optimization 18 (Wiley, 1988)
49. Ma, J. et al. The infinite sites model of genome evolution. Proc. Natl Acad. Sci. USA 105, 14254-14261 (2008)
50. Derrien, T. et al. Fast computation and applications of genome mappability. PLoS ONE 7, e30377-e30377 (2012)
51. Haeno, H. et al. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148, 362-375 (2012)
52. Altrock, P. M., Liu, L. L. & Michor, F. The mathematics of cancer: integrating quantitative models. Nat. Rev. Cancer 15, 730-745 (2015)
53. Maddipati, R. & Stanger, B. Z. Pancreatic cancer metastases harbor evidence of polyclonality. Cancer Discov. 5, 1086-1097 (2015)
54. Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127-1133 (2013)
55. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998)
56. Urosevic, J. et al. Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nat. Cell Biol. 16, 685-694 (2014)
57. Karp, R. M. in Complexity of Computer Computations 85-103 (Springer, 1972)
58. Gusfield, D. Efficient algorithms for inferring evolutionary trees. Networks 21, 19-28 (1991)
59. Athreya, K. B. & Ney, P. E. Branching Processes (Springer-Verlag, 1972)
60. Wodarz, D. & Komarova, N. L. Computational Biology of Cancer: Lecture Notes and Mathematical Modeling (World Scientific Pub. Co. Inc., 2005)
61. Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA 107, 18545-18550 (2010)
62. Reiter, J. G., Bozic, I., Allen, B., Chatterjee, K. & Nowak, M. A. The effect of one additional driver mutation on tumor progression. Evol. Appl. 6, 34-45 (2013)
63. Reiter, J. G., Bozic, I., Chatterjee, K. & Nowak, M. A. in Computer Aided Verification, Lecture Notes in Computer Science 8044, 101-106 (Springer, 2013)
64. Furukawa, H., Iwata, R. & Moriyama, N. Growth rate of pancreatic adenocarcinoma: initial clinical experience. Pancreas 22, 366-369 (2001)
65. Jones, S. S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283-4288 (2008)
66. Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238-244 (2016)
67. Bozic, I., Gerold, J. M. & Nowak, M. A. Quantifying clonal and subclonal passenger mutations in cancer evolution. PLoS Comput. Biol. 12, e1004731 (2016)
68. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010)
69. Schliep, K. P. Phangorn: phylogenetic analysis in R. Bioinformatics 27, 592-593 (2011)
70. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300 (1995)